Atlas Trials

Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

Clinical trial NCT00007527 · COMPLETED

Trial details

NCT number
NCT00007527
Sponsor
US Department of Veterans Affairs
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Opiate Dependence
Start date
1999-08-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.